Intensity Therapeutics

About:

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

Website: http://www.intensitytherapeutics.com

Top Investors: VCapital, Jim Mellon, Batterson Venture Capital, SalvaRx Group PLC, Declan Doogan

Description:

Intensity Therapeutics, Inc., a biopharmaceutical company, provides chemotherapy treatments for cancer patients. It engages in the direct intratumoral injection of novel pharmaceutical formulations for cancer administration. Intensity Therapeutics, Inc. was incorporated in 2012 and is based in Norwalk, Connecticut.

Total Funding Amount:

$36.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Norwalk, Connecticut, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)intensitytherapeutics.com

Founders:

Lewis Bender

Number of Employees:

1-10

Last Funding Date:

2024-11-21

IPO Status:

Public

Industries: